Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

BACKGROUND: Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment and pricing, points towards the inco...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelis, Aris, Lange, Ansgar, Kanavos, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773640/
https://www.ncbi.nlm.nih.gov/pubmed/28303438
http://dx.doi.org/10.1007/s10198-017-0871-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773640/
https://www.ncbi.nlm.nih.gov/pubmed/28303438
http://dx.doi.org/10.1007/s10198-017-0871-0

Ejemplares similares